FDA Proposes Rule to Modernize Drug Manufacturing Registration
First publishedJul 10, 13:07 UTC
Last updatedJul 12, 12:32 UTC · 13m ago
each logo = when that outlet publishedlast updated on Braven
The report
The U.S. Food and Drug Administration today issued a proposed rule that, if finalized, would create a streamlined registration pathway for distributed manufacturing establishments that operate as a single establishment using a “hub-and-spoke” model.
Related in the knowledge graph
organizationDrug AdministrationorganizationFDA Proposes RuleorganizationModernize Drug Manufacturing Registration
Sources (1)
Avg source rating 10.0/10